Development and validation of a model to predict tyrosine kinase inhibitor-sensitive EGFR mutations of non-small cell lung cancer based on multi-institutional data-Reference-Cited by-同舟云学术

Development and validation of a model to predict tyrosine kinase inhibitor-sensitive EGFR mutations of non-small cell lung cancer based on multi-institutional data

Published:2018-10-03 Issue:12 Volume:9 Page:1680-1686
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Chang Hui¹²,Liu Yuan-Bin³⁴,Yi Wei³⁵,Lu Jia-Bin²⁶,Zhang Jie-Xia³⁴^ORCID

Affiliation:

1. Department of Radiation Oncology; Sun Yat-sen University Cancer Center; Guangzhou China

2. State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Guangzhou China

3. Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease; National Clinical Research Center for Respiratory Disease; Guangzhou China

4. Department of Respiratory Medicine; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou China

5. Department of Radiation Oncology; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou China

6. Department of Pathology; Sun Yat-sen University Cancer Center; Guangzhou China

Funder

Key Science and Technology Project of Guangzhou people's Livelihood

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12881/fullpdf

Reference28 articles.